Terms: = Ovarian cancer AND PTK6, BRK, 5753, ENSG00000101213, Q13882, FLJ42088
6 results:
1. Protein-tyrosine phosphatase 1B antagonized signaling by insulin-like growth factor-1 receptor and kinase brk/ptk6 in ovarian cancer cells.
Fan G; Lin G; Lucito R; Tonks NK
J Biol Chem; 2013 Aug; 288(34):24923-34. PubMed ID: 23814047
[TBL] [Abstract] [Full Text] [Related]
2. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT.
Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL
Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128
[TBL] [Abstract] [Full Text] [Related]
3. Global analysis of DNA methylation by Methyl-Capture sequencing reveals epigenetic control of cisplatin resistance in ovarian cancer cell.
Yu W; Jin C; Lou X; Han X; Li L; He Y; Zhang H; Ma K; Zhu J; Cheng L; Lin B
PLoS One; 2011; 6(12):e29450. PubMed ID: 22216282
[TBL] [Abstract] [Full Text] [Related]
4. ptk6 regulates IGF-1-induced anchorage-independent survival.
Irie HY; Shrestha Y; Selfors LM; Frye F; Iida N; Wang Z; Zou L; Yao J; Lu Y; Epstein CB; Natesan S; Richardson AL; Polyak K; Mills GB; Hahn WC; Brugge JS
PLoS One; 2010 Jul; 5(7):e11729. PubMed ID: 20668531
[TBL] [Abstract] [Full Text] [Related]
5. Building a better understanding of the intracellular tyrosine kinase ptk6 - brk by brk.
Brauer PM; Tyner AL
Biochim Biophys Acta; 2010 Aug; 1806(1):66-73. PubMed ID: 20193745
[TBL] [Abstract] [Full Text] [Related]
6. The brk tyrosine kinase is expressed in high-grade serous carcinoma of the ovary.
Schmandt RE; Bennett M; Clifford S; Thornton A; Jiang F; Broaddus RR; Sun CC; Lu KH; Sood AK; Gershenson DM
Cancer Biol Ther; 2006 Sep; 5(9):1136-41. PubMed ID: 16855388
[TBL] [Abstract] [Full Text] [Related]
